Skip to main content
. 2020 Nov 21;163(2):317–329. doi: 10.1007/s00701-020-04652-8

Table 2.

Number and composition of adult operations performed by subspecialty

Adult Pre-COVID-19 COVID-19 p value
Number of operations in N (% of total) 408 (100.0) 173 (100.0)
Functional 37 (9.1) 8 (4.6) p < 0.01
DBSa for Parkinson’s disease/tremor 8 (2.0) 0 (0.0)
Intractable epilepsy/VNSb 18 (4.4) 1 (0.6)
Peripheral nerve 3 (0.7) 1 (0.6)
Baclofen pump/other 2 (0.4) 1 (0.6)
DBS battery change 5 (2.7) 5 (2.9)
Spinal 145 (35.5) 51 (29.5) p < 0.01
Myelopathy 28 ( 6.9) 8 (4.6)
Radiculopathy 73 (17.9) 13 (7.5)
Cauda equina syndrome 26 (6.4) 14 (8.1)
MSCCd and spinal tumour 14 (3.4) 15 (8.7)
Spinal haematoma and other 4 (1.0) 1 (0.6)
Trauma 50 (12.3) 31 (17.9) p > 0.05
Acute subdural hematoma 9 (2.2) 3 (1.7)
Chronic subdural hematoma 26 (6.4) 19 (11.0)
Extradural hematoma 4 (1.0) 2 (1.2)
Traumatic brain injury/other 0 (0.0) 1 (0.6)
Traumatic vertebral fracture 11 (2.7) 5 (2.9)
Vascular 22 (5.4) 9 (5.2) p > 0.05
Aneurysm 9 (2.2) 1 (0.6)
Intracranial haemorrhage 5 (1.2) 5 (2.9)
Ischemic stroke 1 (0.2) 1 (0.6)
Arteriovenous malformation 7 (1.7) 0 (0.0)
Arteriovenous fistula 1 (0.2) 2 (1.2)
Oncology 60 (14.7) 31 (17.9) p > 0.05
Low-grade glioma 4 (1.0) 1 (0.6)
High-grade glioma 31 (7.6) 12 (6.9)
Cerebral metastasis 6 (1.5) 6 (3.5)
Meningioma 13 (3.2) 7 (4.0)
Other 6 (1.5) 5 (2.9)
Skull base 36 (8.8) 7 (4.0) p > 0.05
Pituitary adenoma/apoplexy 16 (3.9) 3 (1.7)
Sphenoid wing meningioma 5 (1.2) 2 (1.2)
Vestibular schwannoma 6 (1.2) 0 (0.0)
Chiari malformation 5 (1.2) 0 (0.0)
Chondrosarcoma 2 (0.5) 0 (0.0)
Trigeminal neuralgia 1 (0.2) 0 (0.0)
Craniopharyngioma 1 (0.2) 2 (1.2)
Other 58 (14.2) 37 (21.4) p > 0.05
Hydrocephalus 30 (7.4) 18 (10.4)
Primary infections 7 (1.7) 4 (2.3)
Secondary infections 15 (3.7) 11 (6.4)
Post-operative hematoma 2 (0.5) 0 (0.0)
CSF leak/pseudomeningocele 4 (1.0) 4 (2.3)

aDeep brain stimulation

bVagal nerve stimulator

cMetastatic spinal cord compression

dCerebrospinal fluid